Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
19 Jun 2013 Just 11 Percent of Adults and 5 Percent of Children Participate in Medical Research Bioethics, legal and economic issues
17 Jun 2013 BioMarker IGF Project Aims to Identify and Validate Biomarkers for the IGF-1 Signalling Pathway in Cancer Personalised medicine
06 Jun 2013 European Medicines Agency recommends granting a marketing authorisation for lipegfilgrastim Anticancer agents & Biologic therapy
05 Jun 2013 Bevacizumab: The First Agent to Remarkably Improve Survival in Recurrent Cervical Cancer Gynaecologic malignancies
04 Jun 2013 European Medicines Agency recommends approval of pomalidomide Haematologic malignancies
03 Jun 2013 FDA Approves Trametinib and Dabrafenib for Unresectable or Metastatic BRAF-Mutated Melanoma Melanoma
14 May 2013 EU funded CAMINEMS project combines three emerging technologies – nanotechnology, optical technologies, and microfluidics Translational research
11 May 2013 Stereotactic ablative radiotherapy is an effective alternative in patients with multiple primary lung cancers Lung and other thoracic tumours
11 May 2013 Initial results from the largest prospective study of pulmonary metastasectomy in patients with colorectal cancer Lung and other thoracic tumours
10 May 2013 Evaluation of performance of lung cancer screening strategy in the first three rounds of the NELSON trial Lung and other thoracic tumours
10 May 2013 Different survival outcome following diagnosis of metastatic bone disease shown for EGFR mutated NSCLC patients in small retrospective study Lung and other thoracic tumours
10 May 2013 First-line gefitinib effective and well tolerated in Caucasian patients with EGFR mutation-positive NSCLC Lung and other thoracic tumours
10 May 2013 Enobosarm improves muscle wasting experienced by patients with NSCLC Lung and other thoracic tumours
10 May 2013 Findings support the value of tumour rebiopsy in NSCLC patients Lung and other thoracic tumours
10 May 2013 Study of simultaneous occurrence of EGFR mutations and HER2 gene amplifications in large series of NSCLC Lung and other thoracic tumours
10 May 2013 Meta-analysis slightly favours platinum-based first-line treatment in patients with advanced/metastatic NSCLC Lung and other thoracic tumours
30 Apr 2013 European Medicines Agency recommends granting a conditional marketing authorisation for vismodegib Anticancer agents & Biologic therapy , Sarcomas
29 Apr 2013 European Medicines Agency recommends granting a marketing authorisation for enzalutamide Anticancer agents & Biologic therapy , Genitourinary cancers
29 Apr 2013 Adequate supply level has been restored in all EU Member States and pegylated doxorubicin hydrochloride can now be used again without restrictions Anticancer agents & Biologic therapy , Breast cancer , Gynaecologic malignancies
26 Apr 2013 New European system for medicines under additional monitoring Anticancer agents & Biologic therapy
25 Apr 2013 Access to cancer medicines in low- and middle-income countries Bioethics, legal and economic issues
24 Apr 2013 A retrospective analysis suggests that patients with NSCLC who harbour specific HER2 mutations may benefit from certain anti-HER2 treatments Lung and other thoracic tumours
23 Apr 2013 New research characterises effectiveness and variability in patient recruitment and retention practices Bioethics, legal and economic issues
22 Apr 2013 Cancer cachexia in the era of obesity Palliative and supportive care
17 Apr 2013 Novel AKT pathway inhibitor, ARQ 092, demonstrates safety, effective target inhibition Anticancer agents & Biologic therapy